Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

A team of scientists from Monash University has identified a single gene in a land plant that could help explain how plants ...

You see these folks on the big screen or hear them on the radio, looking flawless, right? But honestly, even global ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to ...

Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...

Genetix Biotherapeutics Inc. today announced real-world data from the commercial implementation of ZYNTEGLOtm and LYFGENIAtm, first-in-class ex vivo gene addition therapies for the treatment of ...

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the publication of Phase 1/2 ...

The Science Research Program at New Rochelle High School gives students a jump start in careers in advanced sciences.

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...